These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34367449)

  • 1. Orofacial lesions associated with long-term highly active antiretroviral therapy among HIV-seropositive adults in Ibadan, Nigeria.
    Abe OE; Fagbule OF; Olaniyi OO; Adisa AO; Gbolahan OO
    Pan Afr Med J; 2021; 38():370. PubMed ID: 34367449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of HIV related oral lesions in people living with HIV and on combined antiretroviral therapy: a Nigerian experience.
    Mary EO; Abiola OA; Titilola G; Mojirayo OO; Sulaimon AA
    Pan Afr Med J; 2018; 31():180. PubMed ID: 31086631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of long-term use of HAART on oral health status of HIV-infected subjects.
    Nittayananta W; Talungchit S; Jaruratanasirikul S; Silpapojakul K; Chayakul P; Nilmanat A; Pruphetkaew N
    J Oral Pathol Med; 2010 May; 39(5):397-406. PubMed ID: 20202089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks of cardio-vascular diseases among highly active antiretroviral therapy (HAART) treated HIV seropositive volunteers at a treatment centre in Lagos, Nigeria.
    Ekun OA; Fasela EO; Oladele DA; Liboro GO; Raheem TY
    Pan Afr Med J; 2021; 38():206. PubMed ID: 33995812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orofacial lesions in 126 newly diagnosed HIV/AIDS patients seen at the University College Hospital, Ibadan.
    Okoje VN; Obiechina AE; Aken'Ova YA
    Afr J Med Med Sci; 2006 Mar; 35(1):97-101. PubMed ID: 17209335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of HIV associated oral lesions among adults in the era of HAART.
    Mthethwa SR; Wanjau J; Chabikuli N
    SADJ; 2013 Sep; 68(8):364-71. PubMed ID: 24660404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of HIV-related oral manifestations and their association with HAART and CD4+ T cell count: a review.
    Ottria L; Lauritano D; Oberti L; Candotto V; Cura F; Tagliabue A; Tettamanti L
    J Biol Regul Homeost Agents; 2018; 32(2 Suppl. 1):51-59. PubMed ID: 29460518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orofacial manifestations in HIV positive children attending Mildmay Clinic in Uganda.
    Nabbanja J; Gitta S; Peterson S; Rwenyonyi CM
    Odontology; 2013 Jan; 101(1):116-20. PubMed ID: 22362553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral manifestations of an HIV positive cohort in the era of highly active anti-retroviral therapy (HAART) in South London.
    Eyeson JD; Tenant-Flowers M; Cooper DJ; Johnson NW; Warnakulasuriya KA
    J Oral Pathol Med; 2002 Mar; 31(3):169-74. PubMed ID: 11903824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral lesions in Brazilian HIV-infected children undergoing HAART.
    Miziara ID; Filho BC; Weber R
    Int J Pediatr Otorhinolaryngol; 2006 Jun; 70(6):1089-96. PubMed ID: 16406081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of oral mucosal lesions in human immunodeficiency virus-infected children attending the Pediatric Infectious Diseases Clinic in Cape Town.
    Mulder R; Mohamed N; Mathiba O
    Clin Exp Dent Res; 2022 Feb; 8(1):160-168. PubMed ID: 34586712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Changing Clinical Spectrum of Human Immunodeficiency Virus (HIV)-Related Oral Lesions in 1,000 Consecutive Patients: A 12-Year Study in a Referral Center in Mexico.
    Ramírez-Amador V; Esquivel-Pedraza L; Sierra-Madero J; Anaya-Saavedra G; González-Ramírez I; Ponce-de-León S
    Medicine (Baltimore); 2003 Jan; 82(1):39-50. PubMed ID: 12544709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy.
    Schmidt-Westhausen AM; Priepke F; Bergmann FJ; Reichart PA
    J Oral Pathol Med; 2000 Aug; 29(7):336-41. PubMed ID: 10947250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of highly active antiretroviral therapy on frequency of oral warts.
    Greenspan D; Canchola AJ; MacPhail LA; Cheikh B; Greenspan JS
    Lancet; 2001 May; 357(9266):1411-2. PubMed ID: 11356441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
    Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
    J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated infections due to Immune Reconstitution Inflammatory Syndrome after highly active antiretroviral therapy--report of 3 cases from Nigeria.
    Ogoina D; Adekunle V; Obiako R; Umar A; Akolawole M; Ovosi J
    Pan Afr Med J; 2011; 9():38. PubMed ID: 22355437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and echocardiographic findings in a cross-sectional study of HIV-infected adults in Enugu, Nigeria.
    Njoku PO; Ejim EC; Anisiuba BC; Ike SO; Onwubere BJ
    Cardiovasc J Afr; 2021 Nov-Dec 23; 32(6):320-326. PubMed ID: 34128946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV oral lesions in HIV-infected patients: the impact of long-term HAART.
    Anaya-Saavedra G; Flores-Moreno B; García-Carrancá A; Irigoyen-Camacho E; Guido-Jiménez M; Ramírez-Amador V
    J Oral Pathol Med; 2013 Jul; 42(6):443-9. PubMed ID: 23278731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Evaluation of Prevalence, Risk Factors, and Pathologic Features of Kidney Disease in Highly Active Antiretroviral Therapy-Naive and Highly Active Antiretroviral Therapy-Experienced Patients at a Tertiary Health Facility in Maiduguri, Northeastern Nigeria.
    Sulaiman MM; Shettima J; Ummate I; Arogundade FA; Yusuph H; Nwankwo E; Sanusi AA; Akinsola A
    Saudi J Kidney Dis Transpl; 2022; 33(1):72-79. PubMed ID: 36647981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial and Oxidative Impacts of Short and Long-term Administration of HAART on HIV Patients.
    Ikekpeazu JE; Orji OC; Uchendu IK; Ezeanyika LUS
    Curr Clin Pharmacol; 2020; 15(2):110-124. PubMed ID: 31486756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.